322 related articles for article (PubMed ID: 23534931)
1. Discovery of a series of small molecules as potent histone deacetylase inhibitors.
Zhang L; Wang X; Li X; Xu W
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):333-7. PubMed ID: 23534931
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors with enhanced enzymatic inhibition effects and potent in vitro and in vivo antitumor activities.
Zhang L; Zhang Y; Chou CJ; Inks ES; Wang X; Li X; Hou J; Xu W
ChemMedChem; 2014 Mar; 9(3):638-48. PubMed ID: 24227760
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.
Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V
Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412
[TBL] [Abstract][Full Text] [Related]
5. Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives.
Lu W; Wang F; Zhang T; Dong J; Gao H; Su P; Shi Y; Zhang J
Bioorg Med Chem; 2014 May; 22(9):2707-13. PubMed ID: 24702857
[TBL] [Abstract][Full Text] [Related]
6. Discovery of the first histone deacetylase 6/8 dual inhibitors.
Olson DE; Wagner FF; Kaya T; Gale JP; Aidoud N; Davoine EL; Lazzaro F; Weïwer M; Zhang YL; Holson EB
J Med Chem; 2013 Jun; 56(11):4816-20. PubMed ID: 23672185
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.
Zhang L; Wang X; Li X; Zhang L; Xu W
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):582-9. PubMed ID: 24059701
[TBL] [Abstract][Full Text] [Related]
8. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif.
Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H
Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567
[TBL] [Abstract][Full Text] [Related]
9. Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration.
Wang S; Li X; Wei Y; Xiu Z; Nishino N
ChemMedChem; 2014 Mar; 9(3):627-37. PubMed ID: 24285590
[TBL] [Abstract][Full Text] [Related]
10. New aryldithiolethione derivatives as potent histone deacetylase inhibitors.
Tazzari V; Cappelletti G; Casagrande M; Perrino E; Renzi L; Del Soldato P; Sparatore A
Bioorg Med Chem; 2010 Jun; 18(12):4187-94. PubMed ID: 20576572
[TBL] [Abstract][Full Text] [Related]
11. Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors.
Wang F; Lu W; Zhang T; Dong J; Gao H; Li P; Wang S; Zhang J
Bioorg Med Chem; 2013 Nov; 21(22):6973-80. PubMed ID: 24095016
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
[TBL] [Abstract][Full Text] [Related]
13. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors.
Zhang Y; Feng J; Liu C; Zhang L; Jiao J; Fang H; Su L; Zhang X; Zhang J; Li M; Wang B; Xu W
Bioorg Med Chem; 2010 Mar; 18(5):1761-72. PubMed ID: 20171895
[TBL] [Abstract][Full Text] [Related]
16. The discovery of colchicine-SAHA hybrids as a new class of antitumor agents.
Zhang X; Zhang J; Tong L; Luo Y; Su M; Zang Y; Li J; Lu W; Chen Y
Bioorg Med Chem; 2013 Jun; 21(11):3240-4. PubMed ID: 23602523
[TBL] [Abstract][Full Text] [Related]
17. Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.
Cai J; Wei H; Hong KH; Wu X; Zong X; Cao M; Wang P; Li L; Sun C; Chen B; Zhou G; Chen J; Ji M
Bioorg Med Chem; 2015 Jul; 23(13):3457-71. PubMed ID: 25953722
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents.
Huang D; Li X; Sun L; Xiu Z; Nishino N
J Pept Sci; 2012 Apr; 18(4):242-51. PubMed ID: 22253009
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay.
Chen GL; Wang LH; Wang J; Chen K; Zhao M; Sun ZZ; Wang S; Zheng HL; Yang JY; Wu CF
Bioorg Med Chem Lett; 2013 Jul; 23(13):3891-5. PubMed ID: 23707260
[TBL] [Abstract][Full Text] [Related]
20. Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.
Angibaud P; Van Emelen K; Decrane L; van Brandt S; Ten Holte P; Pilatte I; Roux B; Poncelet V; Speybrouck D; Queguiner L; Gaurrand S; Mariën A; Floren W; Janssen L; Verdonck M; van Dun J; van Gompel J; Gilissen R; Mackie C; Du Jardin M; Peeters J; Noppe M; Van Hijfte L; Freyne E; Page M; Janicot M; Arts J
Bioorg Med Chem Lett; 2010 Jan; 20(1):294-8. PubMed ID: 19906529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]